STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD-Reference-Cited by-同舟云学术

STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD

Published:2021-04 Issue:5 Volume:160 Page:1570-1583
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Turner Dan,Ricciuto Amanda,Lewis Ayanna,D’Amico Ferdinando,Dhaliwal Jasbir,Griffiths Anne M.,Bettenworth Dominik,Sandborn William J.,Sands Bruce E.,Reinisch Walter,Schölmerich Jürgen,Bemelman Willem,Danese Silvio,Mary Jean Yves,Rubin David,Colombel Jean-Frederic,Peyrin-Biroulet Laurent,Dotan Iris,Abreu Maria T.,Dignass Axel

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference87 articles.

1. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): determining therapeutic goals for treat-to-target;Peyrin-Biroulet;Am J Gastroenterol,2015

2. Mucosal healing in inflammatory bowel diseases: a systematic review;Neurath;Gut,2012

3. Deep remission at 1 year prevents progression of early Crohn's disease;Ungaro;Gastroenterology,2020

4. Multiparametric evaluation predicts different mid-term outcomes in Crohn's disease;Laterza;Dig Dis,2018

5. Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial;Colombel;Lancet,2019

Cited by 1378 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Focusing on non-responders to infliximab with ulcerative colitis, what can we do first and next?;International Immunopharmacology;2024-11

2. Real-world clinical efficacy of tofacitinib in moderate-to-severe ulcerative colitis;World Journal of Gastroenterology;2024-09-14

3. Effect of past extensive ulcers on fecal calprotectin in ulcerative colitis;2024-09-12

4. Elevated risk of adverse effects from foodborne contaminants and drugs in inflammatory bowel disease: a review;Archives of Toxicology;2024-09-09

5. Why Symptoms Linger in Quiescent Crohn’s Disease: Investigating the Impact of Sulfidogenic Microbes and Sulfur Metabolic Pathways;2024-09-09